Clinical Trials
2
Active:1
Completed:1
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)A Safety and Efficacy Study of PVX108 in Children and Adolescents with Peanut Allergy
Phase 2
Active, not recruiting
- Conditions
- Peanut-Induced AnaphylaxisPeanut HypersensitivityPeanut AllergyImmune System Diseases
- Interventions
- Biological: Placebo
- First Posted Date
- 2022-11-18
- Last Posted Date
- 2024-10-21
- Lead Sponsor
- Aravax Pty Ltd
- Target Recruit Count
- 90
- Registration Number
- NCT05621317
- Locations
- 🇺🇸
Arkansas Children's Research Institute, Little Rock, Arkansas, United States
🇺🇸Peninsula Research Associates, Rolling Hills Estates, California, United States
🇺🇸Children's Healthcare of Atlanta, Atlanta, Georgia, United States
News
No news found